Netscientific Quote - NSCI

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

53.50

Bid

53.00

Offer

54.00

Volume

0.00

0.00 Day's Range 0.00

53.50 52 Week Range 77.00

Market Cap

12.811M

Previous Close

53.50

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,348

Shares Outstanding

23,945,828

Dividend Yield

PE Ratio

-4.17

Earnings Per Share (EPS)

-0.11

Revenue

1.45M

Net Profit

-2.64M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.emvcapital.com

Headquarters

Buckinghamshire, Gbr

Founded

Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 53.50p. Over the last year, Netscientific shares have traded in a share price range of 53.50p to 77.00p.

Netscientific currently has 23,945,828 shares in issue. The market capitalisation of Netscientific is £12.81 million. Netscientific has a price to earnings ratio (PE ratio) of -4.17.

Nanalysis to Present at the LD Micro Main Event XVII

Nanalysis to Present at the LD Micro Main Event XVII PR Newswire CALGARY, AB, Oct. 15, 2024 Presentation at 3:00 PM PT/6:00 PM ET on Wednesday, October 30th CALGARY, AB, Oct. 15, 2024...

NetScientific PLC PDS: Updated Results, VERSATILE-002 Phase 2 Trial

NetScientific PLC 16 September 2024 Immediate release NetScientific plc PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024 Median...

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet

The following is a round-up of updates by London-listed companies, issued on Tuesday and Wednesday and not separately ...

NetScientific PLC PDS Biotech: Business Update and Q2 2024 Results

NetScientific PLC 13 August 2024 Immediate release NetScientific plc PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results NetScientific Plc (AIM:...

NetScientific PLC Replacement RNS: PDS Biotech Aligns with FDA

NetScientific PLC 02 August 2024 Immediate release NetScientific plc Replacement RNS: PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic...

NetScientific PLC PDS Biotech Aligns with FDA on Phase 3 Trial

NetScientific PLC 02 August 2024 RNS: 07.00, 2 August 2024 NetScientific plc PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and...

NetScientific PLC Q-Bot Fundraising

NetScientific PLC 30 July 2024 RNS: 7.00 a.m. on 30 July 2024 NetScientific plc (NetScientific, the Group or the Company) Q-Bot Limited (Q-Bot) Fundraising Issue of Shares and Total...

NetScientific PLC Result of AGM

NetScientific PLC 10 July 2024 NetScientific plc ("NetScientific", the "Group" or the "Company") Result of Annual General Meeting Change of name of Nominated Adviser and Broker ...

NetScientific PLC Notice of AGM

NetScientific PLC 18 June 2024 For release: 07.00, 18 June 2024 NetScientific plc ("NetScientific", the "Group" or the "Company") Notice of AGM and Annual Report & Accounts...

NetScientific PLC TR-1

NetScientific PLC 14 June 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4R5Q82 Issuer Name NetScientific PLC UK or Non-UK Issuer UK 2. Reason for...